Dr. Russell Wyborski has over 25 years of drug discovery and product development experience at Pfizer and Avon Products. His research experience includes work in the Neuroscience, Cardiovascular, Inflammation, and Skin Biology Therapeutic Areas. His main focus in all of these areas has been the regulation of gene expression as it relates to the development of therapeutic agents. He also holds several patents.

Dr. Wyborski received his Ph.D. in Biochemistry from Indiana University. His research on the kinetics of glucagon receptor binding resulted in being awarded the Outstanding Graduate Student Award from the Medical Science Program. He completed a Postdoctoral Fellowship in Neurobiology at the Washington University at St. Louis Medical School focusing on the regulation of the glutamic acid decarboxylase gene. He was awarded a B.S. in Chemistry from the University of Notre Dame.